Altar-Sri Labs Profile
Key Indicators
- Authorised Capital ₹ 6.50 M
as on 07-07-2024
- Paid Up Capital ₹ 4.15 M
as on 07-07-2024
- Company Age 19 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 8.39 Cr
as on 07-07-2024
- Revenue 9.50%
(FY 2022)
- Profit 9.01%
(FY 2022)
- Ebitda -40.19%
(FY 2022)
- Net Worth 12.95%
(FY 2022)
- Total Assets 4.44%
(FY 2022)
About Altar-Sri Labs
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 6.50 M and a paid-up capital of Rs 4.15 M.
The company currently has active open charges totaling ₹8.39 Cr.
Sushil Mittal, Arun Negi, Suresh Mittal, and One other member serve as directors at the Company.
- CIN/LLPIN
U24234HR2005PTC035820
- Company No.
035820
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Aug 2005
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Karnal, Haryana, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Altar-Sri Labs Private Limited offer?
Altar-Sri Labs Private Limited offers a wide range of products and services, including Veterinary Medicines, Veterinary Bolus, Third Party Manufacturing Consultancy, Pharmaceutical Third Party Manufacturing, Anthelmintics, Fenbendazole Tablet, Pharmaceutical Syrup, Oral Suspension, Anti Asthma Drug, Acebrophylline Capsules.
Who are the key members and board of directors at Altar-Sri Labs?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Hemant Negi  | Director | 09-Aug-2005 | Current |
| Sushil Mittal | Director | 23-Aug-2005 | Current |
| Arun Negi | Director | 09-Aug-2005 | Current |
| Suresh Mittal | Director | 09-Aug-2005 | Current |
Financial Performance of Altar-Sri Labs.
Altar-Sri Labs Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 9.5% increase. The company also saw a slight improvement in profitability, with a 9.01% increase in profit. The company's net worth Soared by an impressive increase of 12.95%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Altar-Sri Labs?
Unlock access to Altar-Sri Labs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Altar Health Care Private LimitedActive 24 years 11 monthsSuresh Mittal and Hemant Negi are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 07 Nov 2023 | ₹3.00 Cr | Open |
Hdfc Bank Limited Creation Date: 09 Oct 2023 | ₹3.00 Cr | Open |
Others Creation Date: 20 Jun 2020 | ₹1.00 M | Open |
How Many Employees Work at Altar-Sri Labs?
Unlock and access historical data on people associated with Altar-Sri Labs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Altar-Sri Labs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Altar-Sri Labs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
